25 Publications
2012
FGF23 neutralization improves chronic kidney disease-associated hyperparathyroidism yet increases mortality
Shalhoub, VictoriaShalhoub, VictoriaShatzen, Edward MShatzen, Edward MWard, Sabrina CWard, Sabrina CDavis, JamesDavis, JamesStevens, JennitteStevens, JennitteBi, VivianBi, VivianRenshaw, LisaRenshaw, LisaHawkins, NessaHawkins, NessaWang, WeiWang, WeiChen, ChingChen, ChingTsai, Mei-MeiTsai, Mei-MeiCattley, Russell CCattley, Russell CWronski, Thomas JWronski, Thomas JXia, XuechenXia, XuechenLi, XiaodongLi, XiaodongHenley, CharlesHenley, CharlesEschenberg, MichaelEschenberg, MichaelRichards, William G and Richards, William G
Journal of Clinical Investigation, vol. 122, (no. 7), pp. 2543-53, Jul 2012. | Journal Article
2010
Context-dependent role of angiopoietin-1 inhibition in the suppression of angiogenesis and tumor growth: implications for AMG 386, an angiopoietin-1/2-neutralizing peptibody.
Coxon, AngelaBready, JamesMin, HosungKaufman, StephenLeal, JuanYu, DongyinLee, Tani ASun, Ji-RongEstrada, JuanBolon, BradMcCabe, JamesWang, LingRex, KarenCaenepeel, SeanHughes, PaulCordover, DavidKim, HaejinHan, Seog JMichaels, Mark LHsu, EricShimamoto, GrantCattley, Russell CHurh, EunjuNguyen, LinhWang, Shao XNdifor, AnthonyHayward, Isaac JFalcón, Beverly LMc Donald, Donald MLi, LukeBoone, TomKendall, RichardRadinsky, Robert and Oliner, Jonathan D
Molecular cancer therapeutics, vol. 9, (no. 10), pp. 2641-51, 2010/Oct. | Journal Article
2009
Denosumab, a fully human monoclonal antibody to RANKL, inhibits bone resorption and increases BMD in knock-in mice that express chimeric (murine/human) RANKL.
Kostenuik, Paul JNguyen, Hung QMcCabe, JamesWarmington, Kelly SKurahara, CarolSun, NingChen, ChingLi, LukeCattley, Russell CVan, GwynethScully, SheliaElliott, RobinGrisanti, MarioMorony, SeanTan, Hong LAsuncion, FrankLi, XiaodongOminsky, Michael SStolina, MarinaDwyer, DeniseDougall, William CHawkins, NessaBoyle, WilliamSimonet, William S and Sullivan, John K
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, vol. 24, (no. 2), pp. 182-95, 2009/Feb. | Journal Article
 
The calcimimetic AMG 641 abrogates parathyroid hyperplasia, bone and vascular calcification abnormalities in uremic rats
Henley, CharlesDavis, JamesMiller, GeraldShatzen, EdwardCattley, Russell CLi, XiaodongMartin, DavidYao, WeiLane, Nancy and Shalhoub, Victoria
European Journal of Pharmacology, vol. 616, (no. 1-3), pp. 306-313, 2009. | Journal Article
2008
Osteoprotegerin inhibits vascular calcification without affecting atherosclerosis in ldlr(-/-) mice.
Morony, SeanTintut, YinZhang, ZinaCattley, Russell CVan, GwynethDwyer, DeniseStolina, MarinaKostenuik, Paul J and Demer, Linda L
Circulation, vol. 117, (no. 3), pp. 411-20, 2008/Jan/22. | Journal Article
 
Osteoprotegerin Inhibits Vascular Calcification Without Affecting Atherosclerosis in ldlr super((-/-)) Mice
Morony, SeanTintut, YinZhang, ZinaCattley, Russell CVan, GwynethDwyer, DeniseStolina, MarinaKostenuik, Paul J and Demer, Linda L
Circulation, vol. 117, (no. 3), pp. 411-420, 2008. | Journal Article
2007
The effect of granulocyte colony stimulating factor on regional and global myocardial function in the porcine infarct model.
Lee, Steve SNaqvi, Tasneem ZForrester, JamesCattley, Russell CShah, AtmanFrantzen, MalkaMiyamoto, TakashiKaufman, StephenPrice, Matthew JLill, Michael and Makkar, Raj R
International journal of cardiology, vol. 116, (no. 2), pp. 225-30, 2007/Mar/20. | Journal Article
2006
AMG 706, an Oral, Multikinase Inhibitor that Selectively Targets Vascular Endothelial Growth Factor, Platelet-Derived Growth Factor, and Kit Receptors, Potently Inhibits Angiogenesis and Induces Regression in Tumor Xenografts
Polverino, AnthonyCoxon, AngelaStarnes, CharlieDiaz, ZobediaDeMelfi, ThomasWang, LingBready, JamesEstrada, JuanCattley, Russell CKaufman, StephenChen, DanlinGan, YongmeiKumar, GondiMeyer, JamesNeervannan, SeshaAlva, GonzaloTalvenheimo, JaneMontestruque, SilviaTasker, AndrewPatel, VinodRadinsky, Robert and Kendall, Richard
Cancer Research, vol. 66, (no. 17), pp. 8715-8721, 2006. | Journal Article
 
Dkk1-mediated inhibition of Wnt signaling in bone results in osteopenia.
Li, JiLi, XiaodongLi, JiSarosi, IldikoSarosi, IldikoCattley, Russell CCattley, Russell CPretorius, JamesPretorius, JamesAsuncion, FrankAsuncion, FrankGrisanti, MarioGrisanti, MarioMorony, SeanMorony, SeanAdamu, StephenAdamu, StephenGeng, ZhaopoGeng, ZhaopoQiu, WanrongQiu, WanrongKostenuik, PaulKostenuik, PaulLacey, David LLacey, David LSimonet, W. ScottSimonet, W SBolon, BradBolon, BradQian, XuemingQian, XuemingShalhoub, VictoriaShalhoub, VictoriaOminsky, Michael SOminsky, Michael SZhu Ke, HuaZhu Ke, HuaLi, XiaodongRichards, William G and Richards, William G
Bone, vol. 39, (no. 4), pp. 754-66, 2006/Oct. | Journal Article
 
Fully Human Monoclonal Antibodies to Hepatocyte Growth Factor with Therapeutic Potential against Hepatocyte Growth Factor/c-Met-Dependent Human Tumors
Burgess, TeresaCoxon, AngelaMeyer, SusanneSun, JanRex, KarenTsuruda, TraceChen, QingHo, Shu-YinLi, LukeKaufman, StephenMcDorman, KevinCattley, Russell CSun, JilinElliott, GaryZhang, KeFeng, XiaoJia, Xiao-ChiGreen, LarryRadinsky, Robert and Kendall, Richard
Cancer Research, vol. 66, (no. 3), pp. 1721-1729, 2006. | Journal Article
2005
1,25-Dihydroxyvitamin D3 but not cinacalcet HCl (Sensipar/Mimpara) treatment mediates aortic calcification in a rat model of secondary hyperparathyroidism.
Henley, CharlesColloton, MattCattley, Russell CShatzen, EdwardTowler, Dwight ALacey, David and Martin, David
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, vol. 20, (no. 7), pp. 1370-7, 2005/Jul. | Journal Article
 
1,25-Dihydroxyvitamin D3 but not cinacalcet HCl (Sensipar®/Mimpara®) treatment mediates aortic calcification in a rat model of secondary hyperparathyroidism
Henley, CharlesColloton, MattCattley, Russell CShatzen, EdwardTowler, Dwight ALacey, David and Martin, David
Nephrology, Dialysis, Transplantation, vol. 20, (no. 7), pp. 1370-7, Jul 2005. | Journal Article
 
Role of PPARalpha in mediating the effects of phthalates and metabolites in the liver.
Lapinskas, Paula JBrown, SherriLeesnitzer, Lisa MBlanchard, StevenSwanson, CyndiCattley, Russell C and Corton, J C
Toxicology, vol. 207, (no. 1), pp. 149-63, 2005/Feb/1. | Journal Article
2004
Cancer therapeutics: understanding the mechanism of action.
Cattley, Russell C and Radinsky, Robert R
Toxicologic pathology, vol. 32 Suppl 1, pp. 116-21, 2004 Mar-Apr. | Journal Article
 
Decreased longevity and enhancement of age-dependent lesions in mice lacking the nuclear receptor peroxisome proliferator-activated receptor alpha (PPARalpha).
Howroyd, PaulSwanson, CyndiDunn, CorrieCattley, Russell C and Corton, J C
Toxicologic pathology, vol. 32, (no. 5), pp. 591-9, 2004 Sep-Oct. | Journal Article
 
Peroxisome proliferators and receptor-mediated hepatic carcinogenesis.
Cattley, Russell C
Toxicologic pathology, vol. 32 Suppl 2, pp. 6-11, 2004 Jul-Aug. | Journal Article
 
Role of the peroxisome proliferator-activated receptor alpha (PPARalpha) in responses to trichloroethylene and metabolites, trichloroacetate and dichloroacetate in mouse liver.
Laughter, Ashley RDunn, Corrie SSwanson, Cynthia LHowroyd, PaulCattley, Russell C and Corton, J C
Toxicology, vol. 203, (no. 1-3), pp. 83-98, 2004/Oct/15. | Journal Article
 
Suppression of angiogenesis and tumor growth by selective inhibition of angiopoietin-2.
Oliner, JonathanMin, HosungLeal, JuanYu, DongyinRao, ShashirekhaYou, EdwardTang, XiuKim, HaejinMeyer, SusanneHan, Seog JHawkins, NessaRosenfeld, RobertDavy, ElyseGraham, KevinJacobsen, FrederickStevenson, ShirleyHo, JoanneChen, QingHartmann, ThomasMichaels, MarkKelley, MichaelLi, LukeSitney, KarenMartin, FrankSun, Ji-RongZhang, NancyLu, JohnEstrada, JuanKumar, RakeshCoxon, AngelaKaufman, StephenPretorius, JamesScully, SheilaCattley, Russell CPayton, MarcCoats, SteveNguyen, LinhDesilva, BinodhNdifor, AnthonyHayward, IsaacRadinsky, RobertBoone, Tom and Kendall, Richard
Cancer cell, vol. 6, (no. 5), pp. 507-16, 2004/Nov. | Journal Article
2003
Opposing mechanisms of NADPH-cytochrome P450 oxidoreductase regulation by peroxisome proliferators.
Fan, Li-QunColey, JackieMiller, Richard TCattley, Russell C and Corton, J C
Biochemical pharmacology, vol. 65, (no. 6), pp. 949-59, 2003/Mar/15. | Journal Article
 
Role of the peroxisome proliferator-activated receptor alpha in responses to diisononyl phthalate.
Valles, Edith GLaughter, Ashley RDunn, Corrie SCannelle, SabineSwanson, Cynthia LCattley, Russell C and Corton, J C
Toxicology, vol. 191, (no. 2-3), pp. 211-25, 2003/Sep/30. | Journal Article
2002
Delayed liver regeneration in peroxisome proliferator-activated receptor-alpha-null mice.
Anderson, Steven PYoon, LawrenceRichard, Erika BDunn, Corrie SCattley, Russell C and Corton, J C
Hepatology (Baltimore, Md.), vol. 36, (no. 3), pp. 544-54, 2002/Sep. | Journal Article
 
Regulatory effects of novel neurotrophin-1/b cell-stimulating factor-3 (cardiotrophin-like cytokine) on B cell function.
Senaldi, GiorgioStolina, MarinaGuo, JaneFaggioni, RaffaellaMcCabe, SusanKaufman, Stephen AVan, GwynethXu, WeilongFletcher, Frederick ABoone, ThomasChang, Ming ShiSarmiento, Ulla and Cattley, Russell C
Journal of immunology (Baltimore, Md. : 1950), vol. 168, (no. 11), pp. 5690-8, 2002/Jun/1. | Journal Article
2001
Hepatocellular proliferation in response to a peroxisome proliferator does not require TNF[alpha] signaling
Anderson, Steven PDunn, Corrie SCattley, Russell C and Corton, J.Christopher
Carcinogenesis, vol. 22, (no. 11), pp. 1843, Nov 2001. | Journal Article
2000
Apoptosis, mitosis and cyclophilin-40 expression in regressing peroxisome proliferator-induced adenomas
Miller, Richard TAnderson, Steven PCorton, J. C and Cattley, Russell C
Carcinogenesis, vol. 21, (no. 4), pp. 647-52, Apr 2000. | Journal Article
1988
Peroxisome proliferator hepatocarcinogenesis in rats (Dissertation)
Cattley, Russell C (1988).